{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:04:51Z","timestamp":1771272291469,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R & D Program of China","award":["2017YFA0505100"],"award-info":[{"award-number":["2017YFA0505100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770888"],"award-info":[{"award-number":["31770888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31570828"],"award-info":[{"award-number":["31570828"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672953"],"award-info":[{"award-number":["81672953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773085"],"award-info":[{"award-number":["81773085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Natural Science Research","award":["2016A030313838"],"award-info":[{"award-number":["2016A030313838"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.canlet.2019.02.050","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T02:49:16Z","timestamp":1552272556000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction"],"prefix":"10.1016","volume":"451","author":[{"given":"Jie","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.02.050_bib1","first-page":"177","volume":"67","author":"Siegel","year":"2017","journal-title":"Colorectal cancer statistics"},{"key":"10.1016\/j.canlet.2019.02.050_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/521S1a","article-title":"Colorectal cancer","volume":"521","author":"Brody","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.02.050_bib3","first-page":"381","article-title":"The growing challenge of young adults with colorectal cancer","volume":"31","author":"Weinberg","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2019.02.050_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4939-3347-1_17","article-title":"Managing drug resistance in cancer: role of cancer informatics","volume":"1395","author":"Gautam","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2019.02.050_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12976-017-0052-y","article-title":"Modeling multi-mutation and drug resistance: analysis of some case studies","volume":"14","author":"Feizabadi","year":"2017","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.canlet.2019.02.050_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1476-4598-13-83","article-title":"Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma","volume":"13","author":"Lassen","year":"2014","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib7","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1038\/onc.2011.160","article-title":"Raf kinases in cancer-roles and therapeutic opportunities","volume":"30","author":"Maurer","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.02.050_bib8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2217\/pgs.15.140","article-title":"BRAF in metastatic colorectal cancer: the future starts now","volume":"16","author":"Orlandi","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.canlet.2019.02.050_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2017.08.006","article-title":"Targeting BRAF in metastatic colorectal cancer: maximizing molecular approaches","volume":"60","author":"Strickler","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2019.02.050_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/0008-5472.CAN-13-3686","article-title":"B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells","volume":"75","author":"Herr","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","article-title":"From tumour heterogeneity to advances in precision treatment of colorectal cancer","volume":"14","author":"Punt","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.02.050_bib12","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.02.050_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","author":"Prahallad","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.02.050_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gdata.2015.04.015","article-title":"Global gene expression profiling analysis reveals reduction of stemness after B-RAF inhibition in colorectal cancer cell lines","volume":"4","author":"Boerries","year":"2015","journal-title":"Genom Data"},{"key":"10.1016\/j.canlet.2019.02.050_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.02.050_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2015.02.041","article-title":"Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells","volume":"361","author":"Zubrilov","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.050_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-5-76","article-title":"Apigenin inhibits pancreatic cancer cell proliferation through G2\/M cell cycle arrest","volume":"5","author":"Ujiki","year":"2006","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-12-55","article-title":"Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2\/M cell cycle arrest and apoptosis","volume":"12","author":"Ji","year":"2013","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib20","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1038\/onc.2017.287","article-title":"KCTD12 promotes tumorigenesis by facilitating CDC25B\/CDK1\/Aurora A-dependent G2\/M transition","volume":"36","author":"Zhong","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.02.050_bib21","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1158\/0008-5472.CAN-13-3209","article-title":"NUAK2 amplification coupled with PTEN deficiency promotes melanoma development via CDK activation","volume":"75","author":"Namiki","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/onc.2016.254","article-title":"FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21(Cip1) CDK inhibitor","volume":"36","author":"Milewski","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.02.050_bib23","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2174\/1568026616999160812144924","article-title":"Editorial: old drugs learn new tricks: advances and applications for drug repurposing","volume":"16","author":"Liu","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.canlet.2019.02.050_bib24","first-page":"715","article-title":"Efficacy of adefovir dipivoxil therapy in patients with chronic hepatitis B viral infection","volume":"23","author":"Khan","year":"2014","journal-title":"Mymensingh Med. J."},{"key":"10.1016\/j.canlet.2019.02.050_bib25","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.02.050_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.saa.2014.01.066","article-title":"Experimental and molecular docking studies on DNA binding interaction of adefovir dipivoxil: advances toward treatment of hepatitis B virus infections","volume":"125","author":"Shahabadi","year":"2014","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.canlet.2019.02.050_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM200501203520324","article-title":"Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection","volume":"352","author":"Perez-Roldan","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.02.050_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/AAC.46.2.425-433.2002","article-title":"Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro","volume":"46","author":"Delmas","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.canlet.2019.02.050_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-3542(01)00223-6","article-title":"Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus","volume":"55","author":"Julander","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2018.03.039","article-title":"IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness","volume":"425","author":"Xu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.050_bib31","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-13-2735","article-title":"Id1-induced IGF-II and its autocrine\/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2019.02.050_bib32","article-title":"Lipoprotein FtsB in Streptococcus pyogenes binds ferrichrome in two steps with residues Tyr137 and Trp 204 as critical ligands","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.02.050_bib33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-15-1196","article-title":"Competitive binding between Id1 and E2F1 to Cdc20 regulates E2F1 degradation and thymidylate synthase expression to promote esophageal cancer chemoresistance","volume":"22","author":"Li","year":"2016","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2019.02.050_bib34","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1039\/C8FO01137K","article-title":"Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis","volume":"9","author":"Wang","year":"2018","journal-title":"Food & function"},{"key":"10.1016\/j.canlet.2019.02.050_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy0911s64","article-title":"Flow cytometric analysis of cell division by dilution of CFSE and related dyes","author":"Lyons","year":"2013","journal-title":"Curr Protoc Cytom"},{"key":"10.1016\/j.canlet.2019.02.050_bib36","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1158\/1535-7163.MCT-09-0162","article-title":"Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer","volume":"8","author":"Li","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2019.02.050_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcp.2017.01.006","article-title":"Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma","volume":"129","author":"Wang","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.02.050_bib38","doi-asserted-by":"crossref","first-page":"14399","DOI":"10.1038\/ncomms14399","article-title":"Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.02.050_bib39","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/onc.2017.29","article-title":"MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF","volume":"36","author":"Li","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.02.050_bib40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.colsurfb.2017.03.032","article-title":"Drug nanocarriers for cancer chemotherapy based on microemulsions: the case of Vemurafenib analog PLX4720","volume":"154","author":"Theochari","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.canlet.2019.02.050_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5301\/tj.5000316","article-title":"Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data","volume":"101","author":"Quan","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.canlet.2019.02.050_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: key players? Good targets?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib43","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/ncomms7769","article-title":"CDK1 structures reveal conserved and unique features of the essential cell cycle CDK","volume":"6","author":"Brown","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.02.050_bib44","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/MCB.00400-15","article-title":"Histone deacetylase 10 regulates the cell cycle G2\/M phase transition via a novel let-7-HMGA2-cyclin A2 pathway","volume":"35","author":"Li","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.02.050_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12943-018-0870-5","article-title":"LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2019.02.050_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molcel.2016.07.008","article-title":"Molecular principles of gene fusion mediated rewiring of protein interaction networks in cancer","volume":"63","author":"Latysheva","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2019.02.050_bib47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.jproteome.6b00950","article-title":"Identification of genes associated with breast cancer metastasis to bone on a protein-protein interaction network with a shortest path algorithm","volume":"16","author":"Cai","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0192623313506794","article-title":"Targeting the protein-protein interaction between IRS1 and mutant p110alpha for cancer therapy","volume":"42","author":"Hao","year":"2014","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.canlet.2019.02.050_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tips.2013.04.007","article-title":"Targeting protein-protein interactions as an anticancer strategy","volume":"34","author":"Ivanov","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2019.02.050_bib50","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-15-1025","article-title":"Inhibiting DX2-p14\/ARF interaction exerts antitumor effects in lung cancer and delays tumor progression","volume":"76","author":"Oh","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.050_bib52","first-page":"1647","article-title":"Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort","volume":"35","author":"Sakamoto","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.02.050_bib53","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study","volume":"31","author":"Yin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.02.050_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"Ca - Cancer J. Clin."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:42:12Z","timestamp":1565167332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519301491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":54,"alternative-id":["S0304383519301491"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.050","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}